Saturday 17 October 2026 Export RGEN’s income statement to Excel — free account

Repligen Corporation

RGEN Healthcare Medical Instruments & Supplies

Repligen Corporation’s revenue for fiscal 2025 (year ended December 2025) was $738.3 million, up 16.4% from fiscal 2024. In the quarter to June 2026, revenue grew 11.9%, EPS fell 65.4%, free cash flow grew 27.1% and total debt rose 3.25%, each against the same quarter a year earlier.

175.20 8.97 −4.87%

Follow RGEN

Alert me

Market cap: $11.7B
P/E: 234×
Fwd P/E: 112×
Dividend yield: —
F-score: 6/9
Altman Z: 7.49
Beneish M: −2.52
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	4,455.67	188.34	128.07	181.92
P/S ratio Full definition →		10.62	12.48	8.70	9.80
P/FCF ratio Full definition →		134.37	215.98	119.86	126.01
P/Operating CF Full definition →		156.36	358.49	234.66	234.93
P/B ratio Full definition →		3.61	4.38	3.15	3.64
Price to Tangible BV Full definition →		13.08	15.22	10.53	11.84
EV/Sales Full definition →		10.42	12.27	8.48	9.56
EV/EBITDA Full definition →		78.27	60.17	40.12	46.62
EV/Operating CF Full definition →		56.38	77.15	49.51	55.67
EV/FCF Full definition →		131.85	212.32	116.82	122.90
Quick Ratio Full definition →		6.85	6.82	7.42	7.30
Current Ratio Full definition →		8.36	8.37	9.20	9.05
Net Debt/EBITDA Full definition →		(6.62)	(5.35)	(5.94)	(5.52)
Debt/Assets Full definition →		18.40%	18.38%	18.65%	18.68%
Debt/Equity Full definition →		0.26	0.26	0.26	0.26
Asset Turnover Full definition →		0.25	0.26	0.26	0.27
Operating CF/Net income Full definition →		3.23	1.93	3.40	6.54
Capex/Depreciation Full definition →		(0.36)	(0.33)	(0.20)	(0.18)
Interest Coverage Full definition →		3.11	3.25	2.86	2.47
Research and Development Expense of Revenue Full definition →		7.51%	7.03%	7.44%	7.06%
Selling, General and Administrative Expense of Revenue Full definition →		39.02%	38.01%	39.40%	37.53%
Intangible Assets out of Total Assets Full definition →		0.52	0.51	0.50	0.50
Share Based Compensation of Revenue Full definition →		4.75%	4.03%	4.28%	3.93%
Graham Net Nets Full definition →		0.03	0.03	0.05	0.05
Graham Number Full definition →		5.00	27.08	27.81	25.13
Earnings Yield Full definition →		0.02%	0.53%	0.78%	0.55%
Free Cash Flow Yield Full definition →		0.74%	0.46%	0.83%	0.79%
Revenue per Share Full definition →		3.36	3.52	3.45	3.62
Operating CF per Share Full definition →		0.85	0.46	0.50	0.58
Capex per Share Full definition →		(0.10)	(0.14)	(0.09)	(0.11)
Free Cash Flow per Share Full definition →		0.76	0.31	0.41	0.47
Cash per Share Full definition →		13.31	13.65	13.92	14.37
Shareholders Equity per Share Full definition →		37.02	37.45	37.36	37.44
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		37.02	37.45	37.36	37.44
Free Cash Flow Full definition →		42.71	17.59	23.35	26.70
Working Capital Full definition →		965.35	1,001.56	1,035.15	1,067.90
Capital Expenditures Full definition →		(5.39)	(8.11)	(4.95)	(6.07)
Net Current Asset Value Full definition →		255.86	293.82	336.05	362.41
EV/EBIT Full definition →		9,247.62	164.20	100.28	116.20
Capex to Sales Full definition →		0.03	0.04	0.03	0.03
Price to Operating Income Full definition →		9,424.74	167.03	102.89	119.14
Other line items
Average Receivables Full definition →		139.00	146.35	149.48	157.33
Average Payables Full definition →		25.39	31.07	30.80	29.43
Average Inventory Full definition →		171.39	156.71	166.18	171.23
Average Assets Full definition →		2,877.18	2,889.68	2,891.46	2,925.90
Average Common Equity Full definition →		2,049.89	2,039.42	2,045.47	2,086.89

Fold the line items

Columns are period end dates

Stockrow Weekly